Selected research
Industry Growth & Trends
Global Antibody Drug CDMO Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Antibody Drug CDMO Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Antibody Drug CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Antibody Drug CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Antibody Drug CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Antibody Drug CDMO Service market include Abzena, AGC Biologics, Axplora, Batavia Biosciences, ChemExpress, FUJIFILM, GTP Bioways, Halix and MYCENAX, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Antibody Drug CDMO Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Antibody Drug CDMO Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antibody Drug CDMO Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antibody Drug CDMO Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Antibody Drug CDMO Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Antibody Drug CDMO Service Market by Company
Abzena
AGC Biologics
Axplora
Batavia Biosciences
ChemExpress
FUJIFILM
GTP Bioways
Halix
MYCENAX
WuXi Biologics
ProBio
Samsung Biologics
Sigma-Aldrich
Antibody Drug CDMO Service Segment by Type
Customized Service
Lab-based Service
Others
Antibody Drug CDMO Service Segment by Application
Antibody Drug Conjugates
Monoclonal Antibodies
Others
Antibody Drug CDMO Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody Drug CDMO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibody Drug CDMO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody Drug CDMO Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Antibody Drug CDMO Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Customized Service
- Lab-based Service
- Others
Applications
- Antibody Drug Conjugates
- Monoclonal Antibodies
- Others
Companies covered
- Abzena
- AGC Biologics
- Axplora
- Batavia Biosciences
- ChemExpress
- FUJIFILM
- GTP Bioways
- Halix
- MYCENAX
- WuXi Biologics
- ProBio
- Samsung Biologics
- Sigma-Aldrich
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Antibody Drug CDMO Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Antibody Drug CDMO Service Market Size by Region (2021-2032)
- 1.4.1 Global Antibody Drug CDMO Service Market Size by Region (2021-2026)
- 1.4.2 Global Antibody Drug CDMO Service Market Size by Region (2027-2032)
- 1.5 Key Regions Antibody Drug CDMO Service Market Size (2021-2032)
- 1.5.1 North America Antibody Drug CDMO Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Antibody Drug CDMO Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Antibody Drug CDMO Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Antibody Drug CDMO Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Antibody Drug CDMO Service Market Size Growth Rate (2021-2032)
2 Antibody Drug CDMO Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Customized Service
- 2.1.2 Lab-based Service
- 2.1.3 Others
- 2.2 Global Antibody Drug CDMO Service Market Size by Type
- 2.2.1 Global Antibody Drug CDMO Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Antibody Drug CDMO Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Antibody Drug CDMO Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Antibody Drug CDMO Service Market Size by Regions
- 2.3.1 North America Antibody Drug CDMO Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Antibody Drug CDMO Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Antibody Drug CDMO Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Antibody Drug CDMO Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Antibody Drug CDMO Service Market Size Breakdown by Type (2021-2026)
3 Antibody Drug CDMO Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Antibody Drug Conjugates
- 3.1.2 Monoclonal Antibodies
- 3.1.3 Others
- 3.2 Global Antibody Drug CDMO Service Market Size by Application
- 3.2.1 Global Antibody Drug CDMO Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Antibody Drug CDMO Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Antibody Drug CDMO Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Antibody Drug CDMO Service Market Size by Regions
- 3.3.1 North America Antibody Drug CDMO Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Antibody Drug CDMO Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Antibody Drug CDMO Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Antibody Drug CDMO Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Antibody Drug CDMO Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Antibody Drug CDMO Service Industry Trends
- 4.2 Antibody Drug CDMO Service Industry Drivers
- 4.3 Antibody Drug CDMO Service Industry Opportunities and Challenges
- 4.4 Antibody Drug CDMO Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Antibody Drug CDMO Service Revenue (2021-2026)
- 5.2 Global Antibody Drug CDMO Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Antibody Drug CDMO Service Key Company Headquarters & Area Served
- 5.4 Global Antibody Drug CDMO Service Company, Product Type & Application
- 5.5 Global Antibody Drug CDMO Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Antibody Drug CDMO Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Antibody Drug CDMO Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Antibody Drug CDMO Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Abzena
- 6.1.1 Abzena Company Information
- 6.1.2 Abzena Business Overview
- 6.1.3 Abzena Antibody Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Abzena Antibody Drug CDMO Service Product Portfolio
- 6.1.5 Abzena Recent Developments
- 6.2 AGC Biologics
- 6.2.1 AGC Biologics Company Information
- 6.2.2 AGC Biologics Business Overview
- 6.2.3 AGC Biologics Antibody Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 AGC Biologics Antibody Drug CDMO Service Product Portfolio
- 6.2.5 AGC Biologics Recent Developments
- 6.3 Axplora
- 6.3.1 Axplora Company Information
- 6.3.2 Axplora Business Overview
- 6.3.3 Axplora Antibody Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Axplora Antibody Drug CDMO Service Product Portfolio
- 6.3.5 Axplora Recent Developments
- 6.4 Batavia Biosciences
- 6.4.1 Batavia Biosciences Company Information
- 6.4.2 Batavia Biosciences Business Overview
- 6.4.3 Batavia Biosciences Antibody Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Batavia Biosciences Antibody Drug CDMO Service Product Portfolio
- 6.4.5 Batavia Biosciences Recent Developments
- 6.5 ChemExpress
- 6.5.1 ChemExpress Company Information
- 6.5.2 ChemExpress Business Overview
- 6.5.3 ChemExpress Antibody Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 ChemExpress Antibody Drug CDMO Service Product Portfolio
- 6.5.5 ChemExpress Recent Developments
- 6.6 FUJIFILM
- 6.6.1 FUJIFILM Company Information
- 6.6.2 FUJIFILM Business Overview
- 6.6.3 FUJIFILM Antibody Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 FUJIFILM Antibody Drug CDMO Service Product Portfolio
- 6.6.5 FUJIFILM Recent Developments
- 6.7 GTP Bioways
- 6.7.1 GTP Bioways Company Information
- 6.7.2 GTP Bioways Business Overview
- 6.7.3 GTP Bioways Antibody Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 GTP Bioways Antibody Drug CDMO Service Product Portfolio
- 6.7.5 GTP Bioways Recent Developments
- 6.8 Halix
- 6.8.1 Halix Company Information
- 6.8.2 Halix Business Overview
- 6.8.3 Halix Antibody Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Halix Antibody Drug CDMO Service Product Portfolio
- 6.8.5 Halix Recent Developments
- 6.9 MYCENAX
- 6.9.1 MYCENAX Company Information
- 6.9.2 MYCENAX Business Overview
- 6.9.3 MYCENAX Antibody Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 MYCENAX Antibody Drug CDMO Service Product Portfolio
- 6.9.5 MYCENAX Recent Developments
- 6.10 WuXi Biologics
- 6.10.1 WuXi Biologics Company Information
- 6.10.2 WuXi Biologics Business Overview
- 6.10.3 WuXi Biologics Antibody Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 WuXi Biologics Antibody Drug CDMO Service Product Portfolio
- 6.10.5 WuXi Biologics Recent Developments
- 6.11 ProBio
- 6.11.1 ProBio Company Information
- 6.11.2 ProBio Business Overview
- 6.11.3 ProBio Antibody Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 ProBio Antibody Drug CDMO Service Product Portfolio
- 6.11.5 ProBio Recent Developments
- 6.12 Samsung Biologics
- 6.12.1 Samsung Biologics Company Information
- 6.12.2 Samsung Biologics Business Overview
- 6.12.3 Samsung Biologics Antibody Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Samsung Biologics Antibody Drug CDMO Service Product Portfolio
- 6.12.5 Samsung Biologics Recent Developments
- 6.13 Sigma-Aldrich
- 6.13.1 Sigma-Aldrich Company Information
- 6.13.2 Sigma-Aldrich Business Overview
- 6.13.3 Sigma-Aldrich Antibody Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Sigma-Aldrich Antibody Drug CDMO Service Product Portfolio
- 6.13.5 Sigma-Aldrich Recent Developments
7 North America
- 7.1 North America Antibody Drug CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Antibody Drug CDMO Service Market Size by Country (2021-2026)
- 7.3 North America Antibody Drug CDMO Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Antibody Drug CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Antibody Drug CDMO Service Market Size by Country (2021-2026)
- 8.3 Europe Antibody Drug CDMO Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Antibody Drug CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Antibody Drug CDMO Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Antibody Drug CDMO Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Antibody Drug CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Antibody Drug CDMO Service Market Size by Country (2021-2026)
- 10.3 South America Antibody Drug CDMO Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Antibody Drug CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Antibody Drug CDMO Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Antibody Drug CDMO Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst